A multidisciplinary approach to antimicrobial stewardship: evolution into the 21st century.

In the 21st century, we face the problems of escalating antibiotic resistance, difficult-to-treat infections and slowed new drug development. Healthcare practitioners are increasingly recognising the importance of good antimicrobial stewardship. Various strategies such as formulary management, prior approval, clinical pathways, post-prescribing evaluation and intravenous to oral conversion have been used singly or in combination to improve prescribing and reduce costs. Combining a multifaceted approach with a full-time dedicated multidisciplinary team appears to be capable of yielding satisfactory clinical and economic outcomes and most importantly, sustaining efforts of antimicrobial stewardship. The multidisciplinary approach to antibiotic management should be tailored to fit the individual needs of an institution. More data are needed to document effects on curbing resistance.

[1]  R. Recco,et al.  Antibiotic control in a municipal hospital. , 1979, JAMA.

[2]  R. Echols,et al.  A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection. , 1999, The Journal of antimicrobial chemotherapy.

[3]  L. Rice,et al.  An Interventional Program to Improve Antibiotic Use , 2003, The Annals of pharmacotherapy.

[4]  D. T. Bearden,et al.  Impact of Antimicrobial Control Programs on Patient Outcomes , 2003 .

[5]  T. Cate,et al.  Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  D. Malone,et al.  Excessive antibiotic use for acute respiratory infections in the United States. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  K. Wilson,et al.  Documentation of antibiotic prescribing controls in UK NHS hospitals. , 2004, The Journal of antimicrobial chemotherapy.

[8]  S. Levy The antibiotic paradox : how the misuse of antibiotics destroys their curative powers , 2002 .

[9]  P. Bossuyt,et al.  Early switch from intravenous to oral antibiotics: guidelines and implementation in a large teaching hospital. , 1999, The Journal of antimicrobial chemotherapy.

[10]  D. Wennberg,et al.  Antibiotic Optimization: An Evaluation of Patient Safety and Economic Outcomes , 1997 .

[11]  R. Gaynes,et al.  Practices to Improve Antimicrobial Use at 47 US Hospitals the Status of the 1997 SHEA/IDSA Position Paper Recommendations , 2000, Infection Control & Hospital Epidemiology.

[12]  R. Polk Optimal use of modern antibiotics: emerging trends. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  J. Ramirez,et al.  Early switch from intravenous to oral antibiotics in hospitalized patients with bacteremic community-acquired Streptococcus pneumoniae pneumonia. , 2001, Archives of internal medicine.

[14]  R. Ramphal,et al.  Antibiotic restriction in hospitals associated with medical schools. , 1983, American journal of hospital pharmacy.

[15]  P. O'Hanley,et al.  Cost-effectiveness of prospective and continuous parenteral antibiotic control: experience at the Palo Alto Veterans Affairs Medical Center from 1987 to 1989. , 1991, The American journal of medicine.

[16]  J. Powers,et al.  Trends in antimicrobial drug development: implications for the future. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  Norma Terrin,et al.  Favorable Impact of a Multidisciplinary Antibiotic Management Program Conducted During 7 Years , 2003, Infection Control & Hospital Epidemiology.

[18]  D. Gerding,et al.  Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. , 1997, Infection control and hospital epidemiology.

[19]  Jeremy M. Grimshaw,et al.  Changing Provider Behavior: An Overview of Systematic Reviews of Interventions , 2001, Medical care.

[20]  F. Daschner,et al.  Influence of an infectious disease consulting service on quality and costs of antibiotic prescriptions in a university hospital. , 2001, Scandinavian journal of infectious diseases.

[21]  M. Finland,et al.  Usage of antibiotics in a general hospital: effect of requiring justification. , 1974, The Journal of infectious diseases.

[22]  Y. Carmeli,et al.  Health and economic outcomes of vancomycin-resistant enterococci. , 2002, Archives of internal medicine.

[23]  Wertheimer Ai,et al.  The defined daily dose system (DDD) for drug utilization review. , 1986 .

[24]  I. Gould,et al.  Sequential antibiotic therapy for cost containment in the hospital setting: why not? , 2001, The Journal of hospital infection.

[25]  S. Cosgrove,et al.  Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species. , 2002, Archives of internal medicine.

[26]  J. Gums,et al.  A Randomized, Prospective Study Measuring Outcomes after Antibiotic Therapy Intervention by a Multidisciplinary Consult Team , 1999, Pharmacotherapy.

[27]  N. Fishman,et al.  Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospital. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  G. Counts Review and control of antimicrobial usage in hospitalized patients. A recommended collaborative approach. , 1977, Journal of the American Medical Association (JAMA).

[29]  T. Clemmer,et al.  A computer-assisted management program for antibiotics and other antiinfective agents. , 1998, The New England journal of medicine.

[30]  J J Schentag,et al.  Changes in antimicrobial agent usage resulting from interactions among clinical pharmacy, the infectious disease division, and the microbiology laboratory. , 1993, Diagnostic microbiology and infectious disease.

[31]  L. Mandell,et al.  A multidisciplinary hospital-based antimicrobial use program: Impact on hospital pharmacy expenditures and drug use. , 1996, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.

[32]  R. Gross,et al.  Impact of a hospital-based antimicrobial management program on clinical and economic outcomes. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  M. Struelens Multidisciplinary antimicrobial management teams: the way forward to control antimicrobial resistance in hospitals. , 2003, Current opinion in infectious diseases.

[34]  A. Thébault,et al.  Impact of a multidisciplinary approach to the control of antibiotic prescription in a general hospital. , 2003, The Journal of hospital infection.

[35]  D. Horn,et al.  Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. , 1998, JAMA.

[36]  Leon G Smith,et al.  High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[37]  I. Phillips Prudent use of antibiotics: are our expectations justified? , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[38]  R. Quintiliani,et al.  Antibiotic formulary selection. , 1995, The Medical clinics of North America.

[39]  V L Yu,et al.  Empiric antibiotic selection by physicians: evaluation of reasoning strategies. , 1991, The American journal of the medical sciences.

[40]  J. Marr,et al.  Guidelines for improving the use of antimicrobial agents in hospitals: a statement by the Infectious Diseases Society of America. , 1988, The Journal of infectious diseases.

[41]  R. Wunderink,et al.  Erratum: High-dose, short-course levofloxacin for community-acquired pneumonia: A new treatment paradigm (Clinical Infectious Diseases (2003) 37 (752-60)) , 2003 .

[42]  W. Stamm,et al.  Urinary tract infections in women: diagnosis and treatment. , 1989, Annals of internal medicine.

[43]  F. Herrmann,et al.  Effect of a Comprehensive, Multidisciplinary, Educational Program on the Use of Antibiotics in a Geriatric University Hospital , 2004, Journal of the American Geriatrics Society.

[44]  J. Gerberding,et al.  Pharmacist involvement in antimicrobial use at rural community hospitals in four Western states. , 2004, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[45]  Michael H. Miller,et al.  Sequential Parenteral and Oral Ciprofloxacin Regimen versus Parenteral Therapy for Bacteremia: A Pharmacoeconomic Analysis , 1996, The Annals of pharmacotherapy.

[46]  J. McElnay,et al.  Use of a treatment protocol in the management of community-acquired lower respiratory tract infection. , 2000, The Journal of antimicrobial chemotherapy.

[47]  S. Cosgrove,et al.  Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[48]  G Sherman,et al.  The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. , 2000, Chest.

[49]  David Classen,et al.  Implementing Antibiotic Practice Guidelines through Computer-Assisted Decision Support: Clinical and Financial Outcomes , 1996, Annals of Internal Medicine.

[50]  R. Drew Programs promoting timely sequential antimicrobial therapy: an American perspective. , 1998, The Journal of infection.

[51]  A. Wong-Beringer,et al.  Implementing a program for switching from i.v. to oral antimicrobial therapy. , 2001, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[52]  J. Pflomm Strategies for minimizing antimicrobial resistance. , 2002, American Journal of Health-System Pharmacy.

[53]  I. Gould A review of the role of antibiotic policies in the control of antibiotic resistance. , 1999, The Journal of antimicrobial chemotherapy.

[54]  L. Briceland,et al.  Survey of Antibiotic Control Policies in University-Affiliated Teaching Institutions , 1996, The Annals of pharmacotherapy.

[55]  M. Huycke,et al.  Outcomes of an antimicrobial control program in a teaching hospital. , 2000, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[56]  M. Samore,et al.  Evaluation of antibiotic use in a hospital with an antibiotic restriction policy. , 2003, International journal of antimicrobial agents.

[57]  W. Bilker,et al.  Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[58]  C. Bantar,et al.  A hospitalwide intervention program to optimize the quality of antibiotic use: impact on prescribing practice, antibiotic consumption, cost savings, and bacterial resistance. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[59]  J. Ramirez,et al.  Improving Antimicrobial Use: Longitudinal Assessment of an Antimicrobial Team Including a Clinical Pharmacist , 2004, Journal of managed care pharmacy : JMCP.

[60]  P A Gross,et al.  Implementing Practice Guidelines for Appropriate Antimicrobial Usage: A Systematic Review , 2001, Medical care.